Predicate |
Object |
contentType |
Editorial|Comment |
endingPage |
2126 |
issn |
0732-183X 1527-7755 |
issueIdentifier |
13 |
pageRange |
2125-2126 |
publicationName |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
startingPage |
2125 |
bibliographicCitation |
Escudier B. How to interpret phase II data for everolimus plus bevacizumab in renal cell carcinoma. J Clin Oncol. 2010 May 01;28(13):2125–6. doi: 10.1200/jco.2009.27.4951. PMID: 20368540. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec5aa33f969abf9ff95be6e77ca2062e |
date |
2010-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1200/jco.2009.27.4951 https://pubmed.ncbi.nlm.nih.gov/20368540 |
isPartOf |
https://portal.issn.org/resource/ISSN/1527-7755 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
How to Interpret Phase II Data for Everolimus Plus Bevacizumab in Renal Cell Carcinoma |
discusses |
http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0469193 http://id.nlm.nih.gov/mesh/M000602394 http://id.nlm.nih.gov/mesh/M0029863 http://id.nlm.nih.gov/mesh/M0328153 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0443627 http://id.nlm.nih.gov/mesh/M0026339 http://id.nlm.nih.gov/mesh/M0543256 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0460178 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D017322 http://id.nlm.nih.gov/mesh/D007680Q000188 http://id.nlm.nih.gov/mesh/D002292Q000188 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D019317 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D047908Q000037 http://id.nlm.nih.gov/mesh/D017346Q000037 http://id.nlm.nih.gov/mesh/D002292Q000201 http://id.nlm.nih.gov/mesh/D047908Q000378 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D007680Q000473 http://id.nlm.nih.gov/mesh/D000068338 http://id.nlm.nih.gov/mesh/D000068258 http://id.nlm.nih.gov/mesh/D003627 http://id.nlm.nih.gov/mesh/D007680Q000401 http://id.nlm.nih.gov/mesh/D047428Q000008 http://id.nlm.nih.gov/mesh/D007680Q000201 http://id.nlm.nih.gov/mesh/D012107 http://id.nlm.nih.gov/mesh/D017346Q000378 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D020123Q000031 http://id.nlm.nih.gov/mesh/D020123Q000008 http://id.nlm.nih.gov/mesh/D020533Q000008 http://id.nlm.nih.gov/mesh/D002292Q000556 http://id.nlm.nih.gov/mesh/D058570 http://id.nlm.nih.gov/mesh/D002292Q000401 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D006801 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177 |